Genomic Valley Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 0.21 | 0.16 | TBA |
| Operating Expense | 0.06 | 0.03 | 0.04 |
| Net Profit | 0.15 | 0.13 | -0.04 |
| Net Profit Margin | 71.43 | 81.25 | TBA |
| Earning Per Share | 0.48 | 0.42 | -0.15 |
| EBIDTA | 0.15 | 0.13 | -0.04 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 0.21 |
| Operating Expense | 0.06 |
| Net Profit | 0.15 |
| Net Profit Margin | 71.43 |
| Earning Per Share | 0.48 |
| EBIDTA | 0.15 |
| Effective Tax Rate | TBA |
Invest in Genomic Valley Biotech Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | 2.72 | 0.07 | 0.21 |
| Operating Expenses Annual | 1.84 | 0.45 | 0.35 |
| Operating Profit Annual | 0.66 | 0.13 | -0.14 |
| Interest Annual | TBA | 0.04 | 0.18 |
| Depreciation | 0.01 | 0.08 | 0.19 |
| Net Profit Annual | 0.65 | -0.01 | -0.56 |
| Tax Annual | 0.00 | 0.01 | 0.06 |
| Particulars | Mar 2023 |
|---|---|
| Total Revenue Annual | 2.72 |
| Operating Expenses Annual | 1.84 |
| Operating Profit Annual | 0.66 |
| Interest Annual | TBA |
| Depreciation | 0.01 |
| Net Profit Annual | 0.65 |
| Tax Annual | 0.00 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Cash Flow at the Beginning | TBA | 0.01 | 0.04 |
| Cash Flow from Operations | -0.78 | -2.13 | 1.48 |
| Cash Flow from Investing | 1.52 | 3.67 | -1.58 |
| Cash Flow from Financing | -0.70 | -1.55 | 0.07 |
| Cash Flow at the End | 0.04 | TBA | 0.01 |
| Particulars | Mar 2023 |
|---|---|
| Cash Flow at the Beginning | TBA |
| Cash Flow from Operations | -0.78 |
| Cash Flow from Investing | 1.52 |
| Cash Flow from Financing | -0.70 |
| Cash Flow at the End | 0.04 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| PBDIT Margin (%) | 33.82 | -428.57 | -61.90 |
| PBIT Margin (%) | 33.46 | -542.86 | -152.38 |
| PBT Margin (%) | 33.46 | 13,028.57 | 695.24 |
| Net PROFIT Margin (%) | 23.90 | -14.29 | -266.67 |
| Return On Networth / Equity (%) | 28.48 | TBA | TBA |
| Return On Networth /Employed (%) | 25.67 | TBA | TBA |
| Return On Assets (%) | 18.40 | -0.14 | -8 |
| Total Debt / Equity (X) | TBA | 0.21 | 0.32 |
| Asset Turnover Ratio (%) | 0.77 | 0.01 | 0.03 |
| Particulars | Mar 2023 |
|---|---|
| PBDIT Margin (%) | 33.82 |
| PBIT Margin (%) | 33.46 |
| PBT Margin (%) | 33.46 |
| Net PROFIT Margin (%) | 23.90 |
| Return On Networth / Equity (%) | 28.48 |
| Return On Networth /Employed (%) | 25.67 |
| Return On Assets (%) | 18.40 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.77 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | 0.00 | 1.75 | 5.86 |
| Total Current Assets Annual | 2.58 | 1.14 | 0.16 |
| Non Current Assets Annual | 1.84 | 2.66 | 7.45 |
| Total Shareholders Funds Annual | 3.53 | 2.88 | 4.49 |
| Total Assets Annual | 4.42 | 3.80 | 7.62 |
| Particulars | Mar 2023 |
|---|---|
| Fixed Assets Annual | 0.00 |
| Total Current Assets Annual | 2.58 |
| Non Current Assets Annual | 1.84 |
| Total Shareholders Funds Annual | 3.53 |
| Total Assets Annual | 4.42 |
No Data Availabe
